Specify a stock or a cryptocurrency in the search bar to get a summary
Intrasense
ALINSIntrasense SA designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. The company offers Myrian Imaging Layer, a multimodal visualization software platform suite for health industrials; Myrian Studio, a solution for the development of medical imaging applications for innovators, industrial clients, spin-offs, and research labs; and Myrian technologies to develop biomarkers and artificial intelligence solutions. It also provides Myrian Clinical Apps, a portfolio of clinical applications for advanced post-processing, which include Myrian XP-Breast; Myrian XP-Prostate; Myrian XP-Liver; Myrian XP-Mammo; Myrian XP-Lung; Myrian XP-Colon; Myrian XL-Onco, a lesion tracking solutions; Myrian XP-Vessel; Myrian XP-Cardiac; solution for pathology or organ; and various tools for the analysis of MRI, CT, conventional, radiology, and nuclear imaging exams. The company was incorporated in 2004 and is headquartered in Montpellier, France. Address: 1231, avenue du Mondial 98, Montpellier, France, 34000
Analytics
WallStreet Target Price
0.37 EURP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ALINS
Dividend Analytics ALINS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALINS
Stock Valuation ALINS
Financials ALINS
Results | 2019 | Dynamics |